1994
DOI: 10.1016/0021-9150(94)94240-4
|View full text |Cite
|
Sign up to set email alerts
|

Animal pharmacology of CP-148,623, a cholesterol absorption inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
2000
2000

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…CP-148,623 is a synthetic saponin with very low bioavailabilie2 that has been shown to markedly inhibit cholesterol absorption in animal mod-e1s. 14,15,23 It was used in this study to explore the impact of reduced cholesterol absorption on serum LDL cholesterol levels. We found that the drug (600 mg/day) inhibited cholesterol absorption by 38%, increased cholesterol excretion by 71%, and lowered serum LDL cholesterol levels by 12% in healthy volunteers.…”
Section: Discussionmentioning
confidence: 99%
“…CP-148,623 is a synthetic saponin with very low bioavailabilie2 that has been shown to markedly inhibit cholesterol absorption in animal mod-e1s. 14,15,23 It was used in this study to explore the impact of reduced cholesterol absorption on serum LDL cholesterol levels. We found that the drug (600 mg/day) inhibited cholesterol absorption by 38%, increased cholesterol excretion by 71%, and lowered serum LDL cholesterol levels by 12% in healthy volunteers.…”
Section: Discussionmentioning
confidence: 99%